Delivery Order SPE2DB22D6029-SPE2DB26FLSWC
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,742.76 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively procured and will be performed at the company's corporate office location...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a $72,251.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 2, 2025. This non-competed delivery order, which serves as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement, is set to be completed by October 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp on October 11, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. As a child order under a larger contract vehicle, this delivery order supports the federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.16 to AmerisourceBergen Drug Corp on September 18, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is set to be completed by September 19, 2025, and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $41,791.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside contract, issued as a child delivery order under a larger contract vehicle, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB26FLSWCDelivery Order
The Defense Logistics Agency awarded a $1,437.52 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Megestrol 625 mg/5 ml suspension in a 150 ml quantity. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by October 20, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under a larger vehicle structure, enabling the company to fulfill federal pharmaceutical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver pharmaceutical products across multiple therapeutic domains competitively, supporting the Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/17/25 |